Studi trovati: 1

Objective: To investigate the therapeutic effects of a novel fluid resuscitation protocol (early fluid resuscitation plus 2% hydrogen inhalation) on acute kidney injury during septic shock induced by lipopolysaccharide in rats. Methods: Sixty male Wistar rats were randomly divided into four groups (n = 15 per group): control group (C), septic shock group (S), septic shock with early fluid resuscitation group (R), and septic shock with early fluid resuscitation plus 2% hydrogen inhalation group (R+R+H2). The rats were ventilated, and a 2% hydrogen mixture was used in Group R+H2. Lipopolysaccharide (10 mg/kg) was administered to establish the septic shock model in rats and fluid resuscitation was performed in Groups R and R+R+H2. Results: Fluid resuscitation with 2% hydrogen inhalation decreased serum creatinine, blood urea nitrogen, and neutrophil gelatinase-associated lipocalin. It also reduced oxidative stress injury and decreased renal tumor necrosis factor-α and interleukin-6 levels compared with fluid resuscitation alone. Conclusion: Early fluid resuscitation plus 2% hydrogen inhalation provided more protection against AKI during septic shock.


Mehr lesen: https://pubmed.ncbi.nlm.nih.gov/24955162

Membrane convenzionali

M

Nessuna eliminazione completa per l'intera durata di vita

M

Breve durata di conservazione, solitamente solo un anno

M

Elevato rapporto di acque reflue da 1:2 a 1:4 litri

M

Soggetto a elevati carichi di particelle e depositi, con conseguente riduzione della durata utile

M

Nessuna tecnologia brevettata e prodotti per lo più di massa

Membrana Evodrop

N

99,9% di filtrazione efficace senza riduzione

N

Manutenzione dopo 10.000 litri o al più tardi dopo 5 anni

N

Basso rapporto di scarico dell'acqua di lavaggio di 1:1

N

La struttura integrata della superficie riduce al minimo l'adesione di particelle e depositi

N

Processo a membrana protetta (Orbital Osmosis®)

Evodrop utilizza il database IP2Location LITE per la geolocalizzazione IP .